Recombinant Human Dkk-1 N-Terminal Fragment Protein, CF Summary
Product Specifications
Thr32-Ser141, with a C-terminal 6-His tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
9837-DK
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 500 μg/mL in PBS. |
Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Scientific Data
When Recombinant Human Dkk-1 N-Terminal Fragment (Catalog # 9837-DK) is immobilized at 1 µg/mL, 100 µL/well, Recombinant Mouse CKAP4/p63 (Catalog # 9734-CK) binds with an ED50 of 9-54 ng/mL.
Reconstitution Calculator
Background: Dkk-1
Dickkopf related protein 1 (Dkk-1) is
the founding member of the Dickkopf family of proteins that includes Dkk-1, -2,
-3, -4, and a related protein, Soggy (1, 2). Dkk proteins are secreted proteins
that contain two conserved cysteine-rich domains (CRDs), CRD1 (N-terminal) and CRD2 (C-terminal), separated by a linker region. Each domain contains ten cysteine residues (1-3). Mature human Dkk-1 is
a 40 kDa glycosylated protein. Within the N-terminal fragment [amino acids (aa) 32-141] that includes the CRD1, human DKK-1 shares 85% aa sequence identity with mouse Dkk-1. Dkk-1 antagonizes Wnt/beta-catenin signaling, an activity
for which the C-terminal CRD2 is both necessary and sufficient (4, 5),
while the N-terminal CRD1 was required for binding to CKAP4 (6).
However,
crystallographic studies have shown that Dkk-1 interacts with LRP-6 as a
bipartite inhibitor, with both CRDs binding the extracellular domain of
LRP-6
simultaneously (7-9). Dkk-1/LRP-6/Krm2 complex
internalization has been shown to down-regulate Wnt signaling (4, 10). Dkk-1 is
expressed throughout development and antagonizes Wnt-7a during limb development
(11, 12). Other sites of expression include developing neurons, hair follicles,
and the retina (13, 14). The balance between Wnt signaling and Dkk-1 inhibition
is critical for bone formation and homeostasis (15). Insufficient or excess
Dkk-1 activity in bone results in increased or decreased bone density,
respectively (13, 16). In adults, Dkk-1 is expressed in osteoblasts and
osteocytes, and neurons. Cerebral ischemia induces Dkk-1 expression, which
contributes to neuronal cell death (17). Dkk-1 also likely has a complex role in
cancer, as it has been shown to act as a tumor suppressor and also to promote
metastasis (18-20).
- Krupnik, V.E. et al. (1999) Gene 238:301.
- Niehrs, C. (2006) Oncogene 25:7469.
- Bullock, C.M. et al. (2004) Mol. Pharmacol. 65:582.
- Mao, B. et al. (2001) Nature 411:321.
- Brott, B.K. and S.Y. Sokol (2002) Mol. Cell. Biol. 22:6100.
- Kimura, H. et al. (2016) J. Clin. Invest. 126:7.
- Chen, S. et al. (2011) Dev. Cell 21:848.
- Bourhis, E. et al. (2011) Structure 19:1433.
- Cheng, Z. et al. (2011) Nat. Struct. Mol. Biol. 18:1204.
- Mao, B. et al. (2002) Nature 417:664.
- Kemp, C. et al. (2005) Dev. Dyn. 233:1064.
- Adamska, M. et al. (2004) Dev. Biol. 272:134.
- Li, J. et al. (2006) Bone 39:754.
- Verani, R. et al. (2007) J. Neurochem. 100:242.
- Pinzone, J.J. et al. (2009) Blood 113:517.
- Morvan, F. et al. (2006) J. Bone Miner. Res. 21:934.
- Cappuccio, I. et al. (2005) J. Neurosci. 25:2647.
- Menezes, M.E. et al. (2012) Int. J. Cancer 130:1477.
- Li, S. et al. (2013) PLoS One 8:e84944.
- Chen, L. et al. (2013) Mol. Cancer 12:157.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human Dkk-1 N-Terminal Fragment Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Dkk-1 N-Terminal Fragment Protein, CF and earn rewards!
Have you used Recombinant Human Dkk-1 N-Terminal Fragment Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image